ARPA-H, part of HHS, has earmarked up to $142 million for 10 research projects building the tools, data, and infrastructure needed to tackle treatment resistance.

Based on data from the BEACON and NAUTICAL studies, regulatory authorities greenlit the combo for later-line patients.

PDS Biotechnology has completed subject recruitment for stage 1 of its Phase II trial, evaluating the systemic administration of PDS01ADC.

As early-onset colorectal cancer cases rise, primary care providers can help young patients identify the first symptoms and ...

Investing.com -- PDS Biotechnology Corp (NASDAQ: PDSB) stock rose 3.8% after the company announced that its clinical trial for metastatic colorectal cancer treatment has met pre-set criteria for ...

"Colonoscopy is considered the gold-standard when screening for colorectal cancer," says gastroenterologist Dr. Brian McGee, ...

While oncology has relentlessly pursued progress through pharmacological and procedural advances, exercise has occupied a ...

Hemorrhoids and colon cancer can both cause symptoms of rectal bleeding, but diagnosis and treatment are different. It's ...

Individuals with ulcerative colitis have an increased risk for certain types of cancer based on age, instead of treatment type.

Approval was based on results from the DOORwaY90 trial, which demonstrated a 98.5% overall response rate and 100% local tumor control in patients treated with the SIR-Spheres Y-90 resin microspheres ...

Rates of colorectal and other gastrointestinal cancers are rising in Americans under the age of 50, researchers said Tuesday.

Discover new treatments like ART-123 advancing toward approval to prevent long-term nerve damage caused by ...